Use of subcutaneous‐C1 INH for acute therapy and prophylaxis of a child with HAE

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3038|26|3|296-297

ISSN： 0905-6157

Source： PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol.26, Iss.3, 2015-05, pp. : 296-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 105-4538, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 70, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema

By  

Cytogenetic and Genome Research, Vol. 121, Iss. 3-4, 2008-08 ,pp. : 181-188

Karger

Access to resources Recommend Favorite

Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1‐INH

By  

ALLERGY, Vol. 70, Iss. 3, 2015-03 ,pp. : 285-294

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations

By  

ALLERGY, Vol. 70, Iss. 8, 2015-08 ,pp. : 1004-1012

John Wiley & Sons Inc

Access to resources Recommend Favorite